EGFR and non-small cell lung carcinoma: Different genotypes of NSCLC have different propensities for LNM, cases with fusion mutations have a higher risk and burden of LNM than other genotypes, and EGFR mutations are associated with N2 jump metastasis (N2 lymph node metastasis in the absence of N1) in lung adenocarcinoma (91–94).